Deferred Income Tax Liabilities, Net of BIO-TECHNE Corp from 30 Jun 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
BIO-TECHNE Corp quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 30 Jun 2019 to 31 Dec 2025.
  • BIO-TECHNE Corp Deferred Income Tax Liabilities, Net for the quarter ending 31 Dec 2025 was $11,021,000, a 71% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $11,021,000 -$26,702,000 -71% 31 Dec 2025 10-Q 04 Feb 2026 2026 Q2
Q3 2025 $11,273,000 -$38,744,000 -77% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $6,169,000 -$49,694,000 -89% 30 Jun 2025 10-Q 04 Feb 2026 2026 Q2
Q1 2025 $31,924,000 -$31,742,000 -50% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $37,723,000 -$33,852,000 -47% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $50,017,000 -$33,117,000 -40% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $55,863,000 -$33,119,000 -37% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $63,666,000 -$30,941,000 -33% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $71,575,000 -$39,806,000 -36% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $83,134,000 -$29,786,000 -26% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $88,982,000 -$10,012,000 -10% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q1 2023 $94,607,000 -$4,694,000 -4.7% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $111,381,000 +$9,958,000 +9.8% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $112,920,000 +$14,108,000 +14% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $98,994,000 +$5,869,000 +6.3% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q1 2022 $99,301,000 +$900,000 +0.92% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $101,423,000 -$3,919,000 -3.7% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $98,812,000 -$2,562,000 -2.5% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $93,125,000 -$7,965,000 -7.9% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q1 2021 $98,401,000 +$2,223,000 +2.3% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $105,342,000 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $101,374,000 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $101,090,000 +$11,336,000 +13% 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q1 2020 $96,178,000 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q2 2019 $89,754,000 30 Jun 2019 10-K 26 Aug 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.